Products

Merck Animal Health is committed to protecting the health of animals and supporting a safe and affordable food supply. Through our broad portfolio of vaccines, therapeutic medicines, parasiticides, and technology solutions, we help veterinarians, pet owners, farmers, and producers maintain and improve the health of animals.

News Releases

European Commission Grants Marketing Authorization for NOBIVAC NXT HCPChFeLV from Merck Animal Health

S&P Global Animal Health awarded NUMELVI® Best Companion Animal Product and INNOVAX® ND-ILT-IBD Best Food Animal Product. This is the 8th consecutive year that Merck Animal Health earned an S&P Global Award and the first time a company has won the Best Product Companion Animal and Best Product Food Animal awards in the same year.

News Releases

Study from Merck Animal Health Reveals Opportunity to Increase Feline Vaccination through Knowledge Sharing Between Veterinarians and Cat Owners

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of results from a recent global survey of cat owners and veterinarians aimed at uncovering key drivers, barriers and unmet needs affecting feline vaccination compliance.

Featured Stories

Impact of animal health innovation

Animal health rarely makes national headlines, unless a disease outbreak compels it into the spotlight. When our agricultural and veterinary systems work as they should, they’re easily taken for granted.

Featured Stories

New World Screwworm Is Back: What Livestock Producers Need to Know

In today’s world, many of us do not have a strong recognition of the importance that farm animals play in our daily lives. 

News Releases

Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

Merck Animal Health Reinforces Commitment to Help Protect U.S. Livestock from New World Screwworm Threat

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today reaffirmed its ongoing commitment to supporting the cattle industry in its response to the growing threat of New World screwworm (NWS) following confirmation of the first case in U.S. cattle, underscoring the continued need for industry-wide collaboration to combat this devastating parasite. As a leader in livestock health, Merck Animal Health has been on the forefront of developing innovative medicines for the prevention and treatment of NWS, facilitating information sharing and conversation, and providing educational resources for the livestock industry.

News Releases

In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to Help Advance Veterinary Wellbeing

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

News Releases

Merck Animal Health Wins 2025 S&P Global Award in Best Product and Best Product Companion Animal Food Animal Categories for NUMELVI and INNOVAX® ND-IBD-ILT, Respectively

S&P Global Animal Health awarded NUMELVI® Best Companion Animal Product and INNOVAX® ND-ILT-IBD Best Food Animal Product. This is the 8th consecutive year that Merck Animal Health earned an S&P Global Award and the first time a company has won the Best Product Companion Animal and Best Product Food Animal awards in the same year.

IPPE 2026

Please complete the request form below so we can provide support and more information about our products and technologies.